Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing Bioimage AnalysisBioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering
      Flow CytometryGenomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & Administrative Engagement & Belonging
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing Bioimage Analysis BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering >
      Flow CytometryGenomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & AdministrativeEngagement & Belonging
  • Donate
  • Contact
  • Search

Research News

❮News Processing flavonoids, nutritional components of “superfoods,” requires specific gut bacteria

11/30/2022

Processing flavonoids, nutritional components of “superfoods,” requires specific gut bacteria

Cleveland Clinic researchers find that despite general benefits from fruits and vegetables, people need the right gut microbiota to reap the benefits from flavonoids.

Eating a plant-based diet full of flavonoid-rich “superfoods” has been associated with beneficial effects in combating diseases like obesity, Type II diabetes, cardiovascular disease, inflammatory bowel diseases and colon cancer.

Cleveland Clinic researchers are digging deeper to discover why flavonoids – which are abundant in foods like berries, citrus fruits, legumes and teas – seem so beneficial. Their findings highlight the complexity of the gut microbiome and explain why a diet rich in these foods might not provide the same effects for everyone.

When bacteria in the gut break down these components into a substance called 4-HPAA, it alters how our body metabolizes energy, according to results published in the Proceedings of the National Academy of Sciences.

These changes allow the body to more readily process fat. 4-HPAA was associated with reducing obesity and reversing fatty liver disease in preclinical models. The catch: the research showed about only one in a hundred people have all the bacterial enzymes necessary to process flavonoids and produce 4-HPAA.

The findings reinforce that flavonoids can be useful for health conditions like obesity, but provide evidence that supporting a healthy gut microbiome is key to unlocking these benefits.

Jan Claesen, PhD, Cardiovascular and Metabolic Sciences, says that the results could shift focus in the flavonoid research field from the flavonoids themselves to metabolites, the bacterial enzymes in the gut that are responsible for breaking down flavonoids.

“The flavonoid research field is huge, but with this study we begin to chip away at understanding the molecular processes by which they provide health benefits,” Dr. Claesen says. “We can then potentially take advantage of these pathways to personalize nutrition interventions or introduce probiotics to replace missing enzymes that provide these benefits.”

There are four bacterial enzymes necessary to produce 4-HPAA. These enzymes are encoded by specific bacterial genes. Dr. Claesen’s team analyzed genetic data to find out how often these genes occur. The genes were only found in the gut microbes of 7% of healthy people and the full, four-gene pathway required for 4-HPAA production only occurred in about 1% of the population.

Genetics and other factors, like diet, influence the bacteria in the gut. To translate into medical interventions, researchers in Dr. Claesen’s lab are investigating how to cultivate and maintain bacteria in the gut that would produce the necessary enzymes to break down flavonoids.

Clarifying what types of flavonoids break down in response to different enzymes could lead to doctors being able to recommend foods based on the patient’s microbiome. Probiotics are also an avenue for reintroducing and maintaining bacteria populations that could produce these enzymes, but basic research is fundamental to understanding the complex gut microbiome to produce these effects.

 “While others have alluded to the importance of the gut microbiota in this process, our study was the first to directly show this involvement and demonstrates the effects for 4-HPAA as a microbial metabolite,” Dr. Claesen says. “Overall, I expect this will lead to a shift of focus in the field, away from studying the flavonoids themselves, and instead focusing on the gut microbial metabolites.”

Medical interventions need to focus on the enzymes the bacteria produce, not just the name of the species, according to the study. Two bacteria within the same species, like F. plautii, can have different genetic configurations. This would affect the bacteria’s ability to produce the enzymes to break down flavonoids into 4-HPAA.

“The implication for medical interventions is that it’s not sufficient to look for bacteria called F. plautii in someone’s microbiome, because only a subset of F. plautii have the genes to produce relevant enzymes,” Dr. Claesen says. “Two bacteria can both be named F. plautii because of their evolutionary relation, yet they can have distinct metabolic capabilities.”

Featured Experts
Jan Claesen Headshot
Jan
Claesen, PhD
News Category
news
Related News
Connecting the Dots Between Diet, the Gut Microbiome and CancerDr. Andrei Ivanov Receives $2.5 Million to Study Invading Pathogenic BacteriaResearchers Identify Protector of Intestinal Barrier

Research areas

Cardiovascular & Metabolic Sciences

Want To Support Ground-Breaking Research at Cleveland Clinic?

Discover how you can help Cleveland Clinic save lives and continue to lead the transformation of healthcare.

Give to Cleveland Clinic

Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2025 Lerner Research Institute